Table 1. Baseline characteristics.
| Variables | VR (n=80) | Control (n=79) | p |
|---|---|---|---|
| Age, years (±SD) | 62,11 (±13,35) | 65,09 (±11,95) | 0,141 |
| BMI, kg/m² (±SD) | 27,05 (±5,01) | 26,72 (±4,86) | 0,681 |
| Pre-procedure Anxiety†, cm (±SD) | 4,25 (±3,50) | 4,43 (±3,54) | 0,743 |
| Pre-procedure HR, bpm (±SD) | 76,26 (±11,49) | 74,65 (±13,46) | 0,455 |
| Gender male, N (%) | 57 (71,25%) | 50 (63,3%) | 0,285 |
| Previous procedures | 0,151 | ||
| 0 | 26 (32,5%) | 22 (28,2%) | |
| 1 | 13 (16,25%) | 6 (7,7%) | |
| 2+ | 41 (51,25%) | 50 (64,1%) | |
| Ethnicity, n (%) | 0,107 | ||
| White | 70 (88,61%) | 61 (78,21%) | |
| Black | 7 (13,92%) | 9 (11,54%) | |
| Others | 2 (2,53%) | 8 (10,27%) | |
| Bladder Biopsy, n (%) | 9 (11,25%) | 13 (16,46%) | 0,325 |
| Type, n (%) | 0,376 | ||
| Diagnostics | 17 (21,25%) | 17 (21,52%) | |
| Follow-up | 44 (55%) | 50 (63,29%) | |
| Stent removal | 19 (23,75%) | 12 (15,18%) | |
| Cystoscope sheet, n (%) | 0,679 | ||
| Variables | VR (n=80) | Control (n=79) | p |
| 17 Fr | 13 (16,25%) | 15 (18,99%) | |
| 19 Fr | 34 (42,50%) | 36 (45,57%) | |
| 20 Fr | 33 (41,25%) | 27 (34,18%) |
*p<0.05
†VAS scale (0-10)